Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT Therapeutics AS Director's Dealing 2025

Nov 24, 2025

3600_dirs_2025-11-24_47f2aa09-815f-4d35-b08f-47040a6df447.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Per Walday
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 auction monitor Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a) Business name Exact Therapeutics AS
b) LEI code 2138006ZE5JAL39AGD55
4 Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf
transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a) Description of the financial
instrument/type of instrument
Identification code
Share options linked to the shares in Exact Therapeutics AS (ISIN:
NO0010852213)
b) Nature of the transaction Receipt of share options
c) Price(s) and volume(s) Currency Price(s) Volume(s)
NOK
0
0
610,643
d) Aggregated information
-
Aggregated volume
-
Aggregated price
Sum
0
610,643 share options
NOK 0
0
610,643
e) Date of the transaction 2025-11-24
f) Place of the transaction XOFF – Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Amir Snapir
2 Reason for the notification
a) Position/status CMO
b) Initial notification /Amendment Initial notification
3 auction monitor Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a) Business name Exact Therapeutics AS
b) LEI code 2138006ZE5JAL39AGD55
4 Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf
transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a) Description of the financial
instrument/type of instrument
Identification code
Share options linked to the shares in Exact Therapeutics AS (ISIN:
NO0010852213)
b) Nature of the transaction Receipt of share options
c) Price(s) and volume(s) Currency Price(s) Volume(s)
NOK
0
0 120,000
Sum
0
0 610,643
d) Aggregated information
-
Aggregated volume
-
Aggregated price
120,000 share options
NOK 0
e) Date of the transaction 2025-11-24
f) Place of the transaction XOFF – Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name John M. Edminson
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 auction monitor Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a) Business name Exact Therapeutics AS
b) LEI code 2138006ZE5JAL39AGD55
4 Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf
transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a) Description of the financial
instrument/type of instrument
Identification code
Share options linked to the shares in Exact Therapeutics AS (ISIN:
NO0010852213)
b) Nature of the transaction Receipt of share options
c) Price(s) and volume(s) Currency Price(s) Volume(s)
NOK
0
0 60,000
Sum
0
0 610,643
d) Aggregated information
-
Aggregated volume
-
Aggregated price
60,000 share options
NOK 0
e) Date of the transaction 2025-11-24
f) Place of the transaction XOFF – Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Caspar Foghsgaard
2 Reason for the notification
a) Position/status SVP Commercial & BD
b) Initial notification /Amendment Initial notification
3 auction monitor Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a) Business name Exact Therapeutics AS
b) LEI code 2138006ZE5JAL39AGD55
4 Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf
transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a) Description of the financial
instrument/type of instrument
Identification code
Share options linked to the shares in Exact Therapeutics AS (ISIN:
NO0010852213)
b) Nature of the transaction Receipt of share options
c) Price(s) and volume(s) Currency Price(s) Volume(s)
NOK
0
0 60,000
Sum
0
0 610,643
d) Aggregated information
-
Aggregated volume
-
Aggregated price
60,000 share options
NOK 0
e) Date of the transaction 2025-11-24
f) Place of the transaction XOFF – Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Svein Kvåle
2 Reason for the notification
a) Position/status COO
b) Initial notification /Amendment Initial notification
3 auction monitor Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a) Business name Exact Therapeutics AS
b) LEI code 2138006ZE5JAL39AGD55
4 Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf
transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a) Description of the financial
instrument/type of instrument
Identification code
Share options linked to the shares in Exact Therapeutics AS (ISIN:
NO0010852213)
b) Nature of the transaction Receipt of share options
c) Price(s) and volume(s) Currency Price(s) Volume(s)
NOK
0
0 60,000
Sum
0
0 610,643
d) Aggregated information
-
Aggregated volume
-
Aggregated price
60,000 share options
NOK 0
e) Date of the transaction 2025-11-24
f) Place of the transaction XOFF – Outside a trading venue